Tag Archives: IDMC

December, 2018

August, 2018

June, 2018

August, 2016

April, 2016

November, 2015

  • 25 November

    Genmab Halts Late-Stage Lymphoma Trial

    Copenhagen, Denmark; November 23, 2015 – Genmab A/S (OMX: GEN) announced today that the Phase III study of single agent ofatumumab compared to single agent rituximab in patients with follicular non-Hodgkin’s lymphoma (NHL) that has relapsed at least 6 months after completion of treatment with a rituximab-containing regimen will be stopped …